TickerFacts.

Sarepta Therapeutics, Inc. (SRPT): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-6, first reflected in a filing dated 2012-08-07. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

100.12M
Year ended 2025-12-31
+4.6%
3-year compound annual growth
+5.1%
5-year compound annual growth
129.59M2009-12-31: 93.09M2010-12-31: 111.23M2011-12-31: 129.59M2017-12-31: 58.82M2018-12-31: 66.25M2019-12-31: 73.61M2020-12-31: 77.96M2021-12-31: 81.26M2022-12-31: 87.56M2023-12-31: 92.40M2024-12-31: 107.88M2025-12-31: 100.12M100.12M
2009-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31100.12M-7.2%2026-03-02, From 2025-01-01
2024-12-31107.88M+16.8%2026-03-02, From 2024-01-01
2023-12-3192.40M+5.5%2026-03-02, From 2023-01-01
2022-12-3187.56M+7.7%2025-02-28, From 2022-01-01
2021-12-3181.26M+4.2%2024-02-28, From 2021-01-01
2020-12-3177.96M+5.9%2023-02-28, From 2020-01-01
2019-12-3173.61M+11.1%2022-03-01, From 2019-01-01
2018-12-3166.25M+12.6%2021-03-01, From 2018-01-01
2017-12-3158.82Mn/c2020-02-26, From 2017-01-01
No annual figure between 2011-12-31 and 2017-12-31.
2011-12-31129.59M+16.5%2012-03-13, From 2011-01-01
2010-12-31111.23M+19.5%2012-03-13, From 2010-01-01
2009-12-3193.09Mn/a2012-03-13, From 2009-01-01